Ocugen, Inc.
5 Great Valley Parkway, Suite 160
Malvern, Pennsylvania 19355
May 4, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
|
Re: |
Ocugen, Inc. |
|
|
Registration Statement on Form S-3 |
|
|
Filed March 27, 2020 (File No. 333-237456) |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Ocugen, Inc. (the “Company”) hereby requests that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-237456) (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 4:01 PM, eastern time, on May 5, 2020, or as soon as thereafter as is practicable.
Please contact Thomas Mitchell of Pepper Hamilton LLP, counsel to the Company, at (949) 567-3543 to provide notice of effectiveness, or if you have any questions or comments concerning this request.
[Remainder of the page intentionally left blank]
|
|
Very truly yours, | ||
|
|
| ||
|
|
OCUGEN, INC. | ||
|
|
|
| |
|
|
|
| |
|
|
By: |
/s/ Shankar Musunuri | |
|
|
|
Name: |
Shankar Musunuri, Ph.D., MBA |
|
|
|
Title: |
Chief Executive Officer & Chairman |
Ocugen, Inc. — Acceleration Letter